Staff Profile
Publications
- Earl HM, Hiller L, Vallier A-L, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See M-L, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA, Agarwal R, Algurafi H, Allerton R, Archer C, Armstrong A, Bale C, Barraclough L, Barthakur U, Bedi C, Benstead K, Bloomfield D, Bowen R, Bradley C, Brown J, Butt M, Churn M, Cleator S, Cliff J, Crellin P, Daly M, De Silva-Minor S, Dhadda A, Din O, Down S, Earl H, Eaton D, Eichholz A, Epurescu D, Goh C, Goodman A, Grieve R, Hadaki M, Harper-Wynne C, Hayward L, Humphreys A, Innes H, Jafri M, Jegannathen A, Kelleher M, Kristeleit H, Lee D, Lupton S, MacGregor C, Malik Z, Marshall J, McGolick T, Mehra R, Mithal N, Moss C, Moss A, Mukesh M, Neal A, Nelmes D, Neville-Webbe H, Newby J, O'Reilly S, Ostler P, Persic M, Pettit L, Raja F, Reed C, Rigg A, Roe H, Shah N, Simmonds P, Sims E, Smith S, Storey N, Taylor W, Thanvi N, Tipples K, Vaidya J, Varughese M, Vinayan A, Walji N, Waters S, Wright K, Yahya S. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. The Lancet 2019, 393(10191), 2599-2612.
- Plummer C, Bowater S, Hall J, Lawson C, Ooues G, Price S, Smith R, Wilson I, Wright R. Behind the scenes of the European Examination in General Cardiology. Heart 2019, 105(11), 889-890.
- Findlay SG, Gill JH, Plummer R, De-Santis C, Plummer C. Chronic cardiovascular toxicity in the older oncology patient population. Journal of Geriatric Oncology 2019, 10(5), P685-689.
- Ooues G, Plummer C, Hall J, Lawson C, Price S, Smith R, Wilson I, Wright R, Bowater S. How to succeed in the EEGC: A guide for trainees and their trainers. Heart 2019, 105(13), 1044-1045.
- Plummer CJ, Frank CM, Bari Z, Al Hebaishi YS, Klepfer RN, Stadler RW, Ghosh S, Liu S, Mittal S. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial. Heart Rhythm 2018, 15(3), 369-375.
- Mealing S, Woods B, Hawkins N, Cowie MR, Plummer CJ, Abraham WT, Beshai JF, Klein H, Sculpher M. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart 2016, 102(21), 1742-1749.
- Rajan N, Brown S, Ward S, Hainsworth P, Hodgkinson P, Pieniazek P, Husain A, Plummer R. Mesenteric cysts in naevoid basal cell carcinoma syndrome: A mimic of metastatic disease. British Journal of Dermatology 2016, 174(3), 684-685.
- Woods B, Hawkins N, Mealing S, Sutton A, Abraham WT, Beshai JF, Klein H, Sculpher M, Plummer CJ, Cowie MR. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015, 101(22), 1800-1806.
- Lowe MD, Plummer CJ, Manisty CH, Linker NJ. Safe use of MRI in people with cardiac implantable electronic devices. Heart 2015, 101(24), 1950-1953.
- Raju D, Roysam C, Singh R, Clark SC, Plummer C. Unusual cause of hypoxemia after automatic implantable cardioverter-defibrillatorleads extraction. Annals of Cardiac Anaesthesia 2015, 18(4), 599-602.
- Fazal IA, Tynan M, Plummer CJ, Mccomb JM. Remote vs. conventional follow-up of implantable loop recorders; time to diagnosis and overall diagnostic yield is similar. In: ESC Congress 2014. 2014, Barcelona, Spain: Oxford University Press.
- Haney S, Cresti N, Verrill M, Plummer CJ. Cardiac troponin release following standard dose anthracycline-based adjuvant chemotherapy. In: European Society of Cardiology (ESC) Congress 2013. 2013, Amsterdam, Netherlands: Oxford University Press.
- Fazal IA, Shepherd EJ, Tynan M, Plummer CJ, McComb JM. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates. International Journal of Cardiology 2013, 168(2), 848-852.
- Matthews IG, Plummer CJ, Parry SW. Positive versus Negative Adenosine Tests in Unexplained Syncope Presenting to Acute Medical Services. In: British Geriatrics Society Spring Meeting. 2013, Belfast, Ireland: Oxford University Press.
- Okines AFC, Langley RE, Thompson LC, Stenning SP, Stevenson L, Falk S, Seymour M, Coxon F, Middleton GW, Smith D, Evans L, Slater S, Waters J, Ford D, Hall M, Iveson TJ, Petty RD, Plummer C, Allum WH, Blazeby JM, Griffin M, Cunningham D. Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report. Annals of Oncology 2013, 24(3), 702-709.
- Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials. BMC Cancer 2010, 10(1), 337.
- Barrett-Lee PJ, Dixon JM, Farrell C, Jones A, Leonard R, Murray N, Palmieri C, Plummer CJ, Stanley A, Verrill MW. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Annals of Oncology 2009, 20(5), 816-827.
- Jones AL, Verrill M, Barrett-Lee P, Canney P, Wardley A, Barlow M, Robb S, Plummer C, Gilmour I. DEVELOPMENT AND IMPLEMENTATION OF NEW UK NATIONAL CANCER RESEARCH INSTITUTE (NCRI) GUIDELINES FOR PREVENTING AND MANAGING CARDIAC EVENTS WITH TRASTUZUMAB. In: 33rd European Society for Medical Oncology Congress. 2008, Stockholm, Sweden: Oxford University Press.
- Plummer C, Cunningham A, Cunningham M, Charles R, McComb J. An audit of pacing practice in the 33 cardiac networks serving England and Wales. Heart 2007, 93, A45-A46.
- Cunnington M, Plummer C, McDiarmid A, McComb J. Delays to permanent pacemaker implantation: An explanation for low implantation rates in the United Kingdom?. In: Annual Scientific Conference of the British Cardiovascular Society. 2007, Glasgow: Heart, BMJ Group.
- McComb J, Plummer C, Charles R, Cunningham M, Cunningham A. Inequity of access to cardiac pacing: Results of a national survey. Heart 2007, 93, A46-A46.
- McComb J, Plummer C. Lack of knowledge of pacemaker indications at the front line. Heart 2007, 93, A46-A46.
- McComb J, Plummer C. Recognition of ecg abnormalities associated with atrioventricular conduction defects. Heart 2007, 93(s1), A85-A85.
- McComb JM, Plummer CJ, Charles RG, Cunningham MW, Cunningham AD. Inequity of access to pacemaker implantation for bradycardia in England. In: World Congress of Cardiology. 2006, Barcelona, Spain: European Heart Journal: Oxford University Press.
- Plummer CJ, Cunningham AD. Implications of national guidance on pacing mode in the UK. In: World Congress of Cardiology. 2006, Barcelona, Spain: European Heart Journal: Oxford University Press.
- Doherty L, Kumar P, Bexton R, Plummer C, Dark J, Black F, Lordan J. Aortic regurgitation and Churg-Strauss syndrome. QJM: An International Journal of Medicine 2005, 98(10), 772-773.
- Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM, Rickards AF. The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002. Heart 2005, 91(10), 1280-1283.
- Plummer CJ, Irving RJ, McComb JM. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005, 7(3), 266-272.
- Fazal IA, Bhardwaj R, Tynan M, Plummer CJ, Mccomb JM. Remote monitoring of implantable loop recorders: high artefact in the early phase following implant. In: ESC Congress. 2012, Munchen, Germany: Oxford University Press.
- Shepherd E, Tynan M, Plummer C, Zaman A, Lord S, McComb J. Mortality and symptom benefit with cardiac resynchronisation therapy (CRT) in severe heart failure. In: Heart: Annual Conference of the British Cardiac Society. 2004, Manchester, UK: BMJ Group.
- Plummer CJ, Irving RJ, McComb JM. Implications of national guidance for implantable cardioverter deibrillation implantation in the United Kingdom. Pacing and Clinical Electrophysiology 2003, 26(1, Part 2), 479-482.
- Plummer CJ, McComb JM. An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators. Heart 2003, 89(7), 787-788.
- Plummer CJ, McComb JM. Detection of atrial fibrillation by permanent pacemakers: observations from the STOP AF trial. Cardiac Electrophysiology Review 2003, 7(4), 333-340.
- Plummer CJ, Tynan M, McComb JM, Bexton RS. Impact of district hospital pacing centres on regional pacemaker implantation rates. In: Heart: Annual Scientific Conference of the British Cardiac Society. 2003, Glasgow, UK: BMJ Group.
- Plummer CJ, Kieswetter C, Nath S, McComb JM. Impact of nice guidance on implantable cardioverter defibrillator (ICD) implantation an audit of ICD indications in a tertiary centre and a district hospital. In: Heart: Annual Scientific Conference of the British Cardiac Society. 2003, Glasgow, UK: BMJ Group.
- Plummer CJ, Irving RJ, McComb JM. Implications of national guidance on the implantation of implantable cardioverter-defibrillators for arrhythmias. In: European Heart Journal: Congress of the European Society of Cardiology. 2002, Berlin, Germany: Oxford University Press.
- Plummer CJ, McComb JM. Audit of potential implantable cardioverter defibrillator patients. In: European Heart Journal. 2001, Oxford University Press.
- Plummer CJ, Henderson S, Gardener L, McComb JM. The use of permanent pacemakers in the detection of cardiac arrhythmias. Europace 2001, 3(3), 229-232.
- Plummer CJ, Parry G, McComb J. Tachy-brady syndrome six years after cardiac transplantation. HeartWeb 1999, 4(10), U19-U23.
- Plummer CJ. What's in the CARDS?. Diabetic Medicine 2006, 23(7), 711-714.
- Earl H, Hiller L, Vallier A-L, Loi S, McAdam K, Hughes-Davies L, Rea D, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mahler-Araujo B, Provenzano E, Chhabra A, Gasson S, Balmer C, Abraham JE, Caldas C, Hall P, Shinkins B, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA. Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: The PERSEPHONE non-inferiority RCT. Health Technology Assessment 2020, 24(40), 1-230.
- Plummer CJ, Furniss SS, Heslop PS, Walker DJ. Objective assessment of activity in heart disease. In: HEART. 1996.